Evidence map›Paper›PMID 25003202›Full record

SynthesisPloS one2014

Total hip replacement for the treatment of end stage arthritis of the hip: a systematic review and meta-analysis.

Alexander Tsertsvadze, Amy Grove, Karoline Freeman, Rachel Court, Samantha Johnson, Martin Connock, Aileen Clarke, Paul Sutcliffe

Open access · goldAbstract readMeta-AnalysisSystematic Review
In one paragraph

Synthesis in PloS one, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
20citing papers in PubMed, 3 pooled it
4.7field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

20 citing papers in PubMed, 3 syntheses or guidelines pooled it, 49 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Trial
  5. Trial
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Income and Insurance Status Impact Access to Health Care for Hip Osteoarthritis.Arthroscopy, sports medicine, and rehabilitation · 2023
    Article
  12. Review
  13. Review
  14. Simulated Performance of a Xenohybrid Bone Graft (SmartBoneJournal of functional biomaterials · 2019
    Article
  15. Article
  16. Nano-sized AlCell death & disease · 2018
    Article
  17. Article
  18. Cortisol inhibits mTOR signaling in avascular necrosis of the femoral head.Journal of orthopaedic surgery and research · 2017
    Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 1 institution in 1 country.

Alexander TsertsvadzeWarwick Evidence, Division of Health Sciences, Warwick Medical School, The University of Warwick, Coventry, England.
Amy GroveWarwick Evidence, Division of Health Sciences, Warwick Medical School, The University of Warwick, Coventry, England.
Karoline FreemanWarwick Evidence, Division of Health Sciences, Warwick Medical School, The University of Warwick, Coventry, England.
Rachel CourtWarwick Evidence, Division of Health Sciences, Warwick Medical School, The University of Warwick, Coventry, England.
Samantha JohnsonWarwick Evidence, Division of Health Sciences, Warwick Medical School, The University of Warwick, Coventry, England.
Martin ConnockWarwick Evidence, Division of Health Sciences, Warwick Medical School, The University of Warwick, Coventry, England.
Aileen ClarkeWarwick Evidence, Division of Health Sciences, Warwick Medical School, The University of Warwick, Coventry, England.
Paul SutcliffeWarwick Evidence, Division of Health Sciences, Warwick Medical School, The University of Warwick, Coventry, England.
University of Warwick · GB

Funding

Department of Health WMCLAHRC-2014-1
6 · The paper itself

Abstract

backgroundEvolvements in the design, fixation methods, size, and bearing surface of implants for total hip replacement (THR) have led to a variety of options for healthcare professionals to consider. The need to determine the most optimal combinations of THR implant is warranted. This systematic review evaluated the clinical effectiveness of different types of THR used for the treatment of end stage arthritis of the hip.

methodsA comprehensive literature search was undertaken in major health databases. Randomised controlled trials (RCTs) and systematic reviews published from 2008 onwards comparing different types of primary THR in patients with end stage arthritis of the hip were included.

resultsFourteen RCTs and five systematic reviews were included. Patients experienced significant post-THR improvements in Harris Hip scores, but this did not differ between impact types. There was a reduced risk of implant dislocation after receiving a larger femoral head size (36 mm vs. 28 mm; RR = 0.17, 95% CI: 0.04, 0.78) or cemented cup (vs. cementless cup; pooled odds ratio: 0.34, 95% CI: 0.13, 0.89). Recipients of cross-linked vs. conventional polyethylene cup liners experienced reduced femoral head penetration and revision. There was no impact of femoral stem fixation and cup shell design on implant survival rates. Evidence on mortality and complications (aseptic loosening, femoral fracture) was inconclusive.

conclusionsThe majority of evidence was inconclusive due to poor reporting, missing data, or uncertainty in treatment estimates. The findings warrant cautious interpretation given the risk of bias (blinding, attrition), methodological limitations (small sample size, low event counts, short follow-up), and poor reporting. Long-term pragmatic RCTs are needed to allow for more definitive conclusions. Authors are encouraged to specify the minimal clinically important difference and power calculation for their primary outcome(s) as well CONSORT, PRISMA and STROBE guidelines to ensure better reporting and more reliable production and assessment of evidence.

Indexed as

Arthroplasty, Replacement, HipHumansOsteoarthritis, HipQuality ImprovementRandomized Controlled Trials as TopicResearch DesignTreatment Outcome

Identifiers

PMID25003202
PMCPMC4086719
OpenAlexW2162084176

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.